Skip to main content
Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.565
-0.095 (-3.57%)
Aug 14, 2025, 11:45 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2021 FY 2019 FY 2018 FY 2017 2016 - 2018
Period Ending
 Dec '23 Dec '21 Dec '19 Dec '18 Dec '17 2016 - 2018
Gene Therapeutics
3.60M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapeutics Growth
-52.00%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2021 FY 2019 FY 2018 FY 2017 2016 - 2018
Period Ending
 Dec '23 Dec '21 Dec '19 Dec '18 Dec '17 2016 - 2018
United States
3.60M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-52.00%
Log In
Log In
Log In
Log In
Upgrade